Skinvisible Stock Fundamentals
| SKVI Stock | USD 0.55 0.07 11.29% |
Skinvisible fundamentals help investors to digest information that contributes to Skinvisible's financial success or failures. It also enables traders to predict the movement of Skinvisible OTC Stock. The fundamental analysis module provides a way to measure Skinvisible's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Skinvisible otc stock.
Skinvisible |
Skinvisible OTC Stock Return On Asset Analysis
Skinvisible's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Skinvisible Return On Asset | 0.0678 |
Most of Skinvisible's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Skinvisible is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Skinvisible has a Return On Asset of 0.0678. This is 126.0% higher than that of the Personal Products sector and 98.8% lower than that of the Consumer Staples industry. The return on asset for all United States stocks is 148.43% lower than that of the firm.
Skinvisible Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Skinvisible's current stock value. Our valuation model uses many indicators to compare Skinvisible value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Skinvisible competition to find correlations between indicators driving Skinvisible's intrinsic value. More Info.Skinvisible is rated second in return on asset category among its peers. It is rated third in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Skinvisible by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Skinvisible's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Skinvisible Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Skinvisible's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Skinvisible could also be used in its relative valuation, which is a method of valuing Skinvisible by comparing valuation metrics of similar companies.Skinvisible is currently under evaluation in return on asset category among its peers.
Skinvisible Fundamentals
| Return On Asset | 0.0678 | |||
| Profit Margin | (1.88) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.03 M | |||
| Shares Outstanding | 4.54 M | |||
| Shares Owned By Insiders | 4.19 % | |||
| Price To Earning | 4.91 X | |||
| Price To Sales | 1.38 X | |||
| Revenue | 663.43 K | |||
| Gross Profit | 660.13 K | |||
| EBITDA | 158.23 K | |||
| Net Income | (1.07 M) | |||
| Cash And Equivalents | 160.34 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 2.58 M | |||
| Debt To Equity | (1.07) % | |||
| Current Ratio | 0.05 X | |||
| Book Value Per Share | (1.38) X | |||
| Cash Flow From Operations | 374.61 K | |||
| Earnings Per Share | (0.19) X | |||
| Beta | -0.27 | |||
| Market Capitalization | 513.09 K | |||
| Total Asset | 227.3 K | |||
| Retained Earnings | (27.83 M) | |||
| Working Capital | (5.53 M) | |||
| Current Asset | 97.12 K | |||
| Current Liabilities | 5.63 M | |||
| Net Asset | 227.3 K |
About Skinvisible Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Skinvisible's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Skinvisible using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Skinvisible based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada. Skinvisible operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 2 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Skinvisible OTC Stock
Skinvisible financial ratios help investors to determine whether Skinvisible OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Skinvisible with respect to the benefits of owning Skinvisible security.